Delivery Order SPE2DB22D3401-SPE2DB25FT0KZ
Award Date
10/30/24
Potential Completion Date
10/31/24
Potential Value
$5.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,178.86, is for the supply of GLATOPA 20 MG/ML SYRINGEML, a pharmaceutical product. The contract has a firm fixed-price pricing type and an ultimate completion date of July 9, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,719.99, is for the supply of GLATOPA 40 MG/ML SYRINGEML, a medical product. The contract has an ultimate completion date of October 18, 2023 and is a firm fixed-price delivery order. No set-aside designation was used for this award. AmerisourceBergen Drug Corp...
This federal contract award, valued at $32,419.13, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of GLATOPA 40 MG/ML SYRINGEML, a pharmaceutical product, with a period of performance ending on March 4, 2025. This contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $3,377.68 Firm Fixed Price delivery order is for the supply of GLATOPA 40 MG/ML SYRINGEML, a pharmaceutical product. The contract has a period of performance through May 10, 2022 and does not include any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds...
This federal contract award, valued at $1,385.38, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of GLATOPA 40 MG/ML SYRINGEML, a pharmaceutical product. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC, valued at up to...
This federal contract award, with a ceiling value of $6,173.19, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, a Delivery Order under the DLA Troop Support Medical Indefinite Delivery Contract (IDC), is for the supply of GLATOPA 20 MG/ML SYRINGEML, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of March 4, 2025. This...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $20,356.38 firm fixed price delivery order is for the supply of GLATOPA 20 MG/ML SYRINGE, a multiple sclerosis medication, to support military treatment programs and facilities. The award falls under an indefinite delivery contract (IDC) held by Amerisourcebergen Drug...
This federal contract award, with ID SPE2DB22D1202|SPE2DB24FUMX6, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $36,772.75 firm fixed-price delivery order is for the supply of GLATOPA 40 MG/ML SYRINGEML, a pharmaceutical product. The contract has an ultimate completion date of January 22, 2024 and was awarded on January 19, 2024. It is not designated as a set-aside contract....
This contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of GLATOPA 40 MG/ML SYRINGEML, a specialty medication. The $20,480.50 firm-fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of January 10, 2023. The award is not designated as a set-aside contract. It is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support...
This federal contract award, valued at $3,016.93, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of GLATOPA 40 MG/ML SYRINGEML, a pharmaceutical product, with a completion date of September 30, 2021. The contract is a Delivery Order under a broader Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen...